Comparative Safety and Efficacy of Rivaroxaban, Dabigatran and Apixaban in Obese and Morbidly Obese Patients With Heart Failure and Non-Valvular Atrial Fibrillation: A Real World Analysis

被引：0
|
作者：
Chugh, Yashasvi [1 ]
Krishna, Hanumanthu B. [2 ]
Ayala, Renato Q. [2 ]
Zepeda, Ignacio [2 ]
Li Dan [2 ]
Gonzalez, Carola A. [1 ,2 ]
Patel, Kavisha [1 ,2 ]
Gongora, Carlos [1 ]
Kallur, Ramya
Rastogi, Ujjwal
Piplani, Shobhit [3 ]
Chugh, Sanjay K. [4 ]
Grushko, Michael [5 ]
Faillace, Robert T. [5 ]
机构：
[1] Mt Sinai St Lukes & West Hosp, Cardiol, New York, NY USA
[2] Albert Einstein Coll Med, Jacobi Med Ctr, Med, Bronx, NY 10467 USA
[3] Sawai Man Singh Med Coll & Hosp, Med, Jaipur, Rajasthan, India
[4] JNU Hosp & Med Ctr, Cardiol, Jaipur, Rajasthan, India
[5] Albert Einstein Coll Med, Jacobi Med Ctr, Cardiol, Bronx, NY 10467 USA
来源：
CIRCULATION | 2018年 / 138卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A15192
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Safety and efficacy of apixaban, dabigatran and rivaroxaban in obese and morbidly obese patients with heart failure and atrial fibrillation: A real-world analysis
    Chugh, Yashasvi
    Gupta, Kashvi
    Krishna, Hanumanthu Balram
    Ayala, Renato Quispe
    Zepeda, Ignacio
    Grushko, Michael
    Faillace, Robert T.
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2023, 46 (01): : 50 - 58
  • [2] Comparative effectiveness and safety of apixaban, dabigatran, and rivaroxaban in patients with non-valvular atrial fibrillation
    Andersson, Niklas W.
    Svanstrom, Henrik
    Lund, Marie
    Pasternak, Bjorn
    Melbye, Mads
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 268 : 113 - 119
  • [3] Comparative Effectiveness, Safety, and Costs of Rivaroxaban and Warfarin Among Morbidly Obese Patients With Non-Valvular Atrial Fibrillation
    Peterson, Eric D.
    Ashton, Veronica
    Chen, Yen-Wen
    Wu, Bingcao
    Mangla, Kamal Kant
    Spyropoulos, Alex C.
    [J]. CIRCULATION, 2018, 138
  • [4] Network meta-analysis of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with non-valvular atrial fibrillation
    Marx, S.
    Diener, H. -C.
    Harenberg, J.
    Lip, G.
    Marder, V.
    Wehling, M.
    Weiss, C.
    [J]. EUROPEAN HEART JOURNAL, 2012, 33 : 815 - 815
  • [5] A Real-World Comparison of Apixaban and Rivaroxaban in Obese and Morbidly Obese Patients With Nonvalvular Atrial Fibrillation
    Burnham, Kevin T.
    Yang, Tianrui
    Wooster, Jessica
    [J]. JOURNAL OF PHARMACY PRACTICE, 2024, 37 (04) : 916 - 921
  • [6] Comparison of the efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with non-valvular atrial fibrillation using network meta-analysis
    Marx, Svetlana
    Harenberg, Job
    Wehling, Martin
    Weiss, Christel
    Diener, Hans-Christoph
    Marder, Victor J.
    Lip, Gregory Y. H.
    [J]. THROMBOSIS RESEARCH, 2012, 130 : S100 - S101
  • [7] Real World Bleeding Risks in Non-valvular Atrial Fibrillation Patients With Heart Failure: Contemporary EHR Results Among Prescribed Apixaban, Dabigatran, Rivaroxaban and Warfarin
    Lin, Iris
    Horblyuk, Ruslan
    Mardekian, Jack
    Park, Sang Hee
    Kamble, Shital
    Hamilton, Melissa
    Abdulsattar, Younos
    Petkun, William
    Menzin, Joseph
    Lip, Gregory Y.
    [J]. CIRCULATION, 2016, 134
  • [8] Real-world comparison of bleeding risks among non-valvular atrial fibrillation patients prescribed apixaban, dabigatran, or rivaroxaban
    Tepper, Ping G.
    Mardekian, Jack
    Masseria, Cristina
    Phatak, Hemant
    Kamble, Shital
    Abdulsattar, Younos
    Petkun, William
    Lip, Gregory Y. H.
    [J]. PLOS ONE, 2018, 13 (11):
  • [9] BLEEDING RISK AMONG JAPANESE NON-VALVULAR ATRIAL FIBRILLATION PATIENTS INITIATED ON APIXABAN, DABIGATRAN, RIVAROXABAN OR WARFARIN IN THE REAL WORLD
    Wang, Feng
    Murata, Tatsunori
    Izumi, Naoko
    Kida, Makoto
    Horblyuk, Ruslan
    Terayama, Yasuo
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 443 - 443
  • [10] Direct comparison of dabigatran, apixaban, rivaroxaban and edoxaban for effectiveness and safety among patients with non-valvular atrial fibrillation
    Choi, E. -K.
    Lee, S. R.
    Kwon, S.
    Han, K. D.
    Jung, J. H.
    Oh, S.
    Lip, G. Y. H.
    [J]. EUROPEAN HEART JOURNAL, 2019, 40 : 2986 - 2986
12345